GDF15 Restrains Myocardial Ischemia-reperfusion Injury Through Inhibiting GPX4 Mediated Ferroptosis

Overview

Journal Aging (Albany NY)

Specialty Geriatrics

Date 2024 Jan 11

PMID 38206295

Authors

Qingfeng Gao

Chao Li

Peiqi Zhong

Yunqiang Yu

Zhurong Luo

Hao Chen

Affiliations

Soon will be listed here.

Abstract

Background: Growth and differentiation factor 15 (GDF15) has been proved to regulate the process of Myocardial ischemia-reperfusion injury (MIRI), which is a serious complication of reperfusion therapy. The present study aimed to explore if GDF15 could regulate the MIRI-induced ferroptosis.

Method: MIRI animal model was established by ligating the left anterior descending coronary artery. Oxygen-glucose deprivation/reoxygenation (OGD/R) cell model was established to imitate MIRI . The indicators of ferroptosis including mitochondrial damage, GPX4, FACL4, XCT4, and oxidative stress markers were evaluated.

Results: Overexpression of GDF15 greatly inhibited MIRI, improved cardiac function, alleviated MIRI-induced ferroptosis. pc-DNA-GDF15 significantly inhibited the oxidative stress condition and inflammation response. The OGD/R-induced ferroptosis was also inhibited by pc-DNA-GDF15.

Conclusion: We proved that the MIRI-induced ferroptosis could by inhibited by pc-DNA-GDF15 through evaluating mitochondrial damage, MDA, GSH, and GSSG. Our research provides a new insight for the prevention and treatment of MIRI, and a new understanding for the mechanism of MIRI-induced ferroptosis.

Citing Articles

Ferroptosis and myocardial ischemia-reperfusion: mechanistic insights and new therapeutic perspectives.

Jin B, Zhang Z, Zhang Y, Yang M, Wang C, Xu J Front Pharmacol. 2024; 15:1482986.

PMID: 39411064 PMC: 11473306. DOI: 10.3389/fphar.2024.1482986.

Integrative analysis of transcriptomics and metabolomics reveals the protective effect and mechanism of salidroside on testicular ischemia-reperfusion injury.

Jiang Y, Liu B, Dang Y, Liu L, Pang Y, Bai X Front Pharmacol. 2024; 15:1377836.

PMID: 38818379 PMC: 11137215. DOI: 10.3389/fphar.2024.1377836.

The mechanism by which piR-000699 targets SLC39A14 regulates ferroptosis in aging myocardial ischemia/reperfusion injury.

Chi H, Chai Y, Ma L, Wang Y, Wu Q, Wang L Acta Biochim Biophys Sin (Shanghai). 2024; 56(9):1352-1364.

PMID: 38439666 PMC: 11532203. DOI: 10.3724/abbs.2024024.

References

Yang L, Jian Y, Zhang Z, Qi B, Li Y, Long P . Network-pharmacology-based research on protective effects and underlying mechanism of Shuxin decoction against myocardial ischemia/reperfusion injury with diabetes. World J Diabetes. 2023; 14(7):1057-1076. PMC: 10401449. DOI: 10.4239/wjd.v14.i7.1057. View

Liu L, Pang J, Qin D, Li R, Zou D, Chi K . Deubiquitinase OTUD5 as a Novel Protector against 4-HNE-Triggered Ferroptosis in Myocardial Ischemia/Reperfusion Injury. Adv Sci (Weinh). 2023; 10(28):e2301852. PMC: 10558642. DOI: 10.1002/advs.202301852. View

Zhang M, Pan K, Liu Q, Zhou X, Jiang T, Li Y . Growth differentiation factor 15 may protect the myocardium from no‑reflow by inhibiting the inflammatory‑like response that predominantly involves neutrophil infiltration. Mol Med Rep. 2015; 13(1):623-32. PMC: 4686086. DOI: 10.3892/mmr.2015.4573. View

Pang P, Si W, Wu H, Ju J, Liu K, Wang C . YTHDF2 Promotes Cardiac Ferroptosis Degradation of SLC7A11 in Cardiac Ischemia-Reperfusion Injury. Antioxid Redox Signal. 2023; 40(16-18):889-905. DOI: 10.1089/ars.2023.0291. View

Zhuang L, Zong X, Yang Q, Fan Q, Tao R . Interleukin-34-NF-κB signaling aggravates myocardial ischemic/reperfusion injury by facilitating macrophage recruitment and polarization. EBioMedicine. 2023; 95:104744. PMC: 10433018. DOI: 10.1016/j.ebiom.2023.104744. View

Sun J, Fan J, Yang F, Su X, Li X, Tian L . Effect and possible mechanisms of saponins in Chinese herbal medicine exerts for the treatment of myocardial ischemia-reperfusion injury in experimental animal: a systematic review and meta-analysis. Front Cardiovasc Med. 2023; 10:1147740. PMC: 10410164. DOI: 10.3389/fcvm.2023.1147740. View

Qiu M, Yan W, Liu M . YAP Facilitates NEDD4L-Mediated Ubiquitination and Degradation of ACSL4 to Alleviate Ferroptosis in Myocardial Ischemia-Reperfusion Injury. Can J Cardiol. 2023; 39(11):1712-1727. DOI: 10.1016/j.cjca.2023.07.030. View

Yu P, Zhang J, Ding Y, Chen D, Sun H, Yuan F . Dexmedetomidine post-conditioning alleviates myocardial ischemia-reperfusion injury in rats by ferroptosis inhibition via SLC7A11/GPX4 axis activation. Hum Cell. 2022; 35(3):836-848. DOI: 10.1007/s13577-022-00682-9. View

Wu X, Wang B, Zhou Y, Yang Z, Jiang L, Kou Z . NLRP3 inflammasome inhibitor MCC950 reduces cerebral ischemia/reperfusion induced neuronal ferroptosis. Neurosci Lett. 2022; 795:137032. DOI: 10.1016/j.neulet.2022.137032. View

10.

Wang R, Dong S, Xia R, Sun M, Sun Y, Ren H . Kinsenoside mitigates myocardial ischemia/reperfusion-induced ferroptosis via activation of the Akt/Nrf2/HO-1 pathway. Eur J Pharmacol. 2023; 956:175985. DOI: 10.1016/j.ejphar.2023.175985. View

11.

Dong W, Weng J, Zhu J, Zheng Y, Liu L, Dong C . CREB-binding protein and HIF-1α/β-catenin to upregulate miR-322 and alleviate myocardial ischemia-reperfusion injury. FASEB J. 2023; 37(9):e22996. DOI: 10.1096/fj.202200596RRRRRR. View

12.

Wu S, Zhu J, Wu G, Hu Z, Ying P, Bao Z . 6-Gingerol Alleviates Ferroptosis and Inflammation of Diabetic Cardiomyopathy via the Nrf2/HO-1 Pathway. Oxid Med Cell Longev. 2023; 2022:3027514. PMC: 9825225. DOI: 10.1155/2022/3027514. View

13.

Ding S, Duanmu X, Xu L, Zhu L, Wu Z . Ozone pretreatment alleviates ischemiareperfusion injury-induced myocardial ferroptosis by activating the Nrf2/Slc7a11/Gpx4 axis. Biomed Pharmacother. 2023; 165:115185. DOI: 10.1016/j.biopha.2023.115185. View

14.

Zhang Y, Moszczynski L, Liu Q, Jiang J, Zhao D, Quan D . Over-expression of growth differentiation factor 15 (GDF15) preventing cold ischemia reperfusion (I/R) injury in heart transplantation through Foxo3a signaling. Oncotarget. 2017; 8(22):36531-36544. PMC: 5482674. DOI: 10.18632/oncotarget.16607. View

15.

Wang L, Liu J, Wang Z, Qian X, Zhao Y, Wang Q . Dexmedetomidine abates myocardial ischemia reperfusion injury through inhibition of pyroptosis via regulation of miR-665/MEF2D/Nrf2 axis. Biomed Pharmacother. 2023; 165:115255. DOI: 10.1016/j.biopha.2023.115255. View

16.

Kindernay L, Ferenczyova K, Farkasova V, Bartekova M, Bernatova I, Ravingerova T . Effects of Iron Nanoparticles Administration on Ischemia/Reperfusion Injury in Isolated Hearts of Male Wistar Rats. Physiol Res. 2023; 72(S1):S61-S72. PMC: 10292812. DOI: 10.33549/physiolres.935112. View

17.

Tan B, Li Y, Zhao Q, Fan L, Wang D . ZNF139 increases multidrug resistance in gastric cancer cells by inhibiting . Biosci Rep. 2018; 38(5). PMC: 6123064. DOI: 10.1042/BSR20181023. View

18.

Chen W, Zhang Y, Wang Z, Tan M, Lin J, Qian X . Dapagliflozin alleviates myocardial ischemia/reperfusion injury by reducing ferroptosis MAPK signaling inhibition. Front Pharmacol. 2023; 14:1078205. PMC: 9986553. DOI: 10.3389/fphar.2023.1078205. View

19.

Zhang B, Jiang H, Chen J, Guo X, Li Y, Hu Q . Corrigendum to "Nobiletin ameliorates myocardial ischemia and reperfusion injury by attenuating endoplasmic reticulum stress-associated apoptosis through regulation of the PI3K/AKT signal pathway" [Int. Immunopharmacol 73 (2019) 98-107]. Int Immunopharmacol. 2023; 122:110769. DOI: 10.1016/j.intimp.2023.110769. View

20.

Ge C, Peng Y, Li J, Wang L, Zhu X, Wang N . Hydroxysafflor Yellow A Alleviates Acute Myocardial Ischemia/Reperfusion Injury in Mice by Inhibiting Ferroptosis via the Activation of the HIF-1α/SLC7A11/GPX4 Signaling Pathway. Nutrients. 2023; 15(15). PMC: 10420812. DOI: 10.3390/nu15153411. View